Gut

Article	Citations
Unusual history of ‘stitch’	1828
Response to McAlindon’s letter	1623
Innumerable nodules in all parts of the small intestine	1045
Crohn’s disease and ulcerative colitis exhibit prediagnostic antibody signatures with shared and divergent changes towards disease onset	469
Finding a mate for MLCK: improving the potential for therapeutic targeting of gut permeability	365
Hepatocyte senescence in alcohol-associated hepatitis: epiphenomenon or disease-driving mechanism?	354
Genetically proxied ketohexokinase function and risk of colorectal cancer: a Mendelian randomisation study	241
Establishment of enterically transmitted hepatitis virus animal models using lipid nanoparticle-based full-length viral genome RNA delivery system	237
IL-3 receptor signalling suppresses chronic intestinal inflammation by controlling mechanobiology and tissue egress of regulatory T cells	236
Absence of a pancreatic microbiome in intraductal papillary mucinous neoplasm	229
Holistic healthcare in inflammatory bowel disease: time for patient-centric approaches?	225
Picking up microbial clues in early-onset colorectal cancer	216
Preclinical stages of Crohn’s disease defined by faecal calprotectin in asymptomatic first-degree relatives: screening framework for prevention trials	213
Defining the key intrahepatic gene networks in HCV infection driven by sex	202
Immunomodulation and entry inhibition: selgantolimod’s double punch against hepatitis B virus	197
Correction: P97 A patient information bundle outlining dietary advice in liver disease specific to the cost of living crisis improves patient care: ‘Looking after Your Liver for	190
Impact of margin thermal ablation after endoscopic mucosal resection of large (≥20 mm) non-pedunculated colonic polyps on long-term recurrence	189
Growth rates and histopathological outcomes of small (6–9 mm) colorectal polyps based on CT colonography surveillance and endoscopic removal	188
Mass cytometry-based peripheral blood analysis as a novel tool for early detection of solid tumours: a multicentre study	181
Third Asia-Pacific consensus recommendations on colorectal cancer screening and postpolypectomy surveillance	181
COVID-19 and liver disease	176
HBcrAg values may predict virological and immunological responses to pegIFN-α in NUC-suppressed HBeAg-negative chronic hepatitis B	176
Gut virome-colonising Orthohepadnavirus genus is associated with ulcerative colitis pathogenesis and induces intestinal inflammation	173
Current therapies and new developments in NASH	171
S100A10 promotes HCC development and progression via transfer in extracellular vesicles and regulating their protein cargos	163

Methionine deficiency facilitates antitumour immunity by altering m6A methylation of immune checkpoint transcripts	163
Liquid biopsy to identify Barrett’s oesophagus, dysplasia and oesophageal adenocarcinoma: the EMERALD multicentre study	154
Where are we with gastric cancer screening in Europe in 2024?	151
Perturbation of mRNA splicing in liver cancer: insights, opportunities and challenges	149
A mucus production programme promotes classical pancreatic ductal adenocarcinoma	146
Reassessing the prophylactic effect of clip closure to prevent delayed rebleeding after colorectal endoscopic submucosal dissection	140
Rate of suitable cases for primary EUS-guided biliary drainage in distal malignant biliary obstruction	136
Autologous regulatory T-cell transfer in refractory ulcerative colitis with concomitant primary sclerosing cholangitis	129
Rare cause of obstructive jaundice	126
Asian Pacific Association of Gastroenterology task force recommendations on surveillance for Helicobacter pylori associated gastric premalignant conditio	125
Large-scale multiomic analysis identifies non-coding somatic driver mutations and nominates ZFP36L2 as a driver gene for pancreatic ductal adenocarcinoma	120
Humoral response to SARS-CoV-2 infection among liver transplant recipients	118
Hypothesis-generating evaluation of multi-armoured oncolytic HSV-1 (VG161) in intrahepatic cholangiocarcinoma: pooled insights from multicentre studies	118
Shaggy white lesion with morphological changes in the oesophagus	113
GI highlights from the literature	112
Time for arginine methylation: PRMT5 inhibition to advance cholangiocarcinoma treatment	112
Endoscopic mucosal and submucosal cutting for long benign oesophageal strictures	110
Decoding HBV-specific adaptive immunity: from natural clearance to cure	110
Need for standardised approaches to human microbiome research using the example of colorectal neoplasia research	109
Interactive enhancer hubs (iHUBs) mediate transcriptional reprogramming and adaptive resistance in pancreatic cancer	109
Intron-mediated enhancement of SPINK1 expression for pancreatitis therapy	109
Faecal occult blood loss accurately predicts future detection of colorectal cancer. A prognostic model	109
Association between appendectomy and Parkinson’s disease from the UK Biobank	108
Tumour-intrinsic alterations and stromal matrix remodelling promote Wnt-niche independence during diffuse-type gastric cancer progression	107
Tiny contributors to severe obesity inside the gut	107
Correction: Inflammatory cell-derived CXCL3 promotes pancreatic cancer metastasis through a novel myofibroblast-hijacked cancer escape mechanism	106
Selective decontamination of the digestive tract in critically ill children: fighting fire with fire or burning down the house?	106
Perplexing case of abdominal pain with eosinophilia and fasciitis	105
Engineered anti-PDL1 with IFNα targets both immunoinhibitory and activating signals in the liver to break HBV immune tolerance	105
Impact of climate change on vulnerable populations	105
Definite benefits of GLP-1 receptor agonists: what is the risk of gastroparesis and lung aspiration?	99
Lumen-apposing metal stents versus double-pigtail plastic stents for infected necrotising pancreatitis: more doubts than answers	99
Most excess years of potential life loss among individuals with cirrhosis during the pandemic were not related to COVID-19	99
Host transcriptome signatures in human faecal-washes predict histological remission in patients with IBD	97
Unveiling 8 years of duodenoscope contamination: insights from a retrospective analysis in a large tertiary care hospital	96
New entity of adult ultra-short coeliac disease: the first international cohort and case–control study	93
British Society of Gastroenterology guidelines on sedation in gastrointestinal endoscopy	92
Integrated multimodel analysis of intestinal inflammation exposes key molecular features of preclinical and clinical IBD	91
Reflux conditions induce E-cadherin cleavage and EMT via APE1 redox function in oesophageal adenocarcinoma	89
MicroRNA-223 attenuates hepatocarcinogenesis by blocking hypoxia-driven angiogenesis and immunosuppression	89
Extracellular Vesicles from Pancreatic Cancer Stem Cells Lead an Intratumor Communication Network (EVNet) to fuel tumour progression	88
24-Nor-ursodeoxycholic acid improves intestinal inflammation by targeting T H 17 pathogenicity and transdifferentiation	85
Combination therapies for metabolic dysfunction-associated steatohepatitis: challenges and opportunities	85
Endoscopic stratification of gastric intestinal metaplasia: where are we, where do we want to go and how do we get there?	84
Gastrointestinal microbiota and inflammasomes interplay in health and disease: a gut feeling	84
Environmental and healthcare trade-offs between single-use and reusable gastroscopes	80
SARS-CoV-2 vaccination in patients with GI and hepatobiliary carcinoma: a call for booster vaccination	80
Treatment of type 2 diabetes with MASLD: new evidence for personalised medicine	80
Reply: Prevalence of serum HBsAg <100 IU/mL in inactive chronic hepatitis B	79
Ebastine for the treatment of irritable bowel syndrome: old drug, new tricks?	79

SMYD2-mediated methylation of STAT1 protects against hepatic ischaemia/reperfusion injury by blocking JAK-STAT1 signalling pathways	79
British Society of Gastroenterology interim framework for addressing the COVID-19-related backlog in inflammatory bowel disease colorectal cancer surveillance	78
APCmosaicism, not always isolated: two first-degree relatives with apparently distinctAPCmosaicism	78
Rethinking routine mapping biopsies in gastric intestinal metaplasia: justification for endoscopic stratification	77
Gut microbe alleviates stress-related cancer metastasis by oleic acid degradation	75
Hypophosphataemia following ferric derisomaltose and ferric carboxymaltose in patients with iron deficiency anaemia due to inflammatory bowel disease (PHOSPHARE-IBD): a randomised clinical trial	74
Endoscopic papillectomy versus surgical ampullectomy for adenomas and early cancers of the papilla: a retrospective Pancreas2000/European Pancreatic Club analysis	74
Postprandial symptoms in disorders of gut-brain interaction and their potential as a treatment target	73
A20-mediated KEAP1 ubiquitination orchestrates hepatocyte ferroptosis to ameliorate autoimmune hepatitis	72
Fasting-mimicking diet-enriched Bifidobacterium pseudolongum suppresses colorectal cancer by inducing memory CD8 +	72
Withdrawal of the British Society of Gastroenterology IBD risk grid for COVID-19 severity	72
Impact of age, comorbidities and relevant changes on surveillance strategy of intraductal papillary mucinous neoplasms: a competing risk analysis	70
Association between inflammatory bowel disease and Alzheimer’s disease: multivariable and bidirectional Mendelian randomisation analyses	70
FSTL1 promotes liver fibrosis by reprogramming macrophage function through modulating the intracellular function of PKM2	69
Correction: Revisiting the role of sphincterotomy in sphincter of oddi disorder: a critical appraisal of the RESPOnD study	68
Correction: Prevalence of irritable bowel syndrome and functional dyspepsia after acute gastroenteritis: systematic review and meta-analysis	67
Does the benefit of haemostatic powder differ by Forrest classification in non-variceal upper gastrointestinal bleeding?	67
Anticoagulation in colorectal ESD: implications for bleeding risk management	67
GI highlights from the literature	66
Enolase represents a metabolic checkpoint controlling the differential exhaustion programmes of hepatitis virus-specific CD8 + T cells	66
Immunopathogenesis and environmental triggers in coeliac disease	65
Targeting MS4A4A on tumour-associated macrophages restores CD8+ T-cell-mediated antitumour immunity	65
Targeting hepatic stellate cells to combat liver fibrosis: where do we stand?	65
Response letter to the editor	63
Submucosal steroid pre-injection strategy to prevent oesophageal stricture after circumferential endoscopic submucosal dissection	62
Prevalence of serum HBsAg <100 IU/mL in inactive chronic hepatitis B	62
Understanding the malignant potential of gastric metaplasia of the oesophagus and its relevance to Barrett’s oesophagus surveillance: individual-level data analysis	61
Crosstalk between liver sinusoidal endothelial cells and hepatocytes via IL-1α–IL1R1 axis exacerbates ischaemia/reperfusion injury in aged livers	60
Gastric emptying study before gastric peroral endoscopic myotomy (G-POEM): can intragastric meal distribution be a predictor of success?	60
Non-invasive assessment of MASH resolution	60
Quest for HBV functional cure: what have we learnt from silencing RNAs?	60
GI highlights from the literature	60
Unravelling the obesity paradox in MASLD patients with extrahepatic cancer	60
It takes two to TAM-go	59
Nuclear Pirin promotes HCC by acting as a key inflammation-facilitating factor	59
GI highlights from the literature	58
Fatal intestinal disease: a case of recurrent lower gastrointestinal bleeding	58
Monocyte phenotypic liquid biopsy for NASH and liver fibrosis diagnosis: a new kid on the block	58
National Institute for Health and Care Excellence (NICE) guidance on monitoring and management of Barrett’s oesophagus and stage I oesophageal adenocarcinoma	57
Porcine-derived pancreatic enzyme replacement therapy may be linked to chronic hepatitis E virus infection in cystic fibrosis lung transplant recipients	57
MED12 loss activates endogenous retroelements to sensitise immunotherapy in pancreatic cancer	57
Molecular portraits of patients with intrahepatic cholangiocarcinoma who diverge as rapid progressors or long survivors on chemotherapy	57
NLRP6 deficiency enhances macrophage-mediated phagocytosis via E-Syt1 to inhibit hepatocellular carcinoma progression	56
Comparison of drugs for active eosinophilic oesophagitis: systematic review and network meta-analysis	55
Clinical relevance of biomarkers in cholangiocarcinoma: critical revision and future directions	55
Spatial dissection of tumour microenvironments in gastric cancers reveals the immunosuppressive crosstalk between CCL2+ fibroblasts and	55
Abnormal gastrointestinal motility is a major factor in explaining symptoms and a potential therapeutic target in patients with disorders of gut–brain interaction	55
A black liver	53
NFATc1 signaling drives chronic ER stress responses to promote NAFLD progression	53
Lysosomal lipid switch sensitises to nutrient deprivation and mTOR targeting in pancreatic cancer	52
ISG15–CREB1 ISGylation: a stellate cell brake in liver fibrosis	52
Autologous T cell responses to primary human colorectal cancer spheroids are enhanced by ectonucleotidase inhibition	52
Dominant-negative effect of lactase missense variants: hetero-complex assembly with the wild-type enzyme impairs intracellular trafficking and digestive function	51
Withdrawal of antitumour necrosis factor in patients with inflammatory bowel disease in remission: a randomised placebo-controlled clinical trial of GETECCU	51
Combining epigenetic modulation: the next step for HCC immunotherapy?	51
Cultivated human intestinal fungus Candida metapsilosis M2006B attenuates colitis by secreting acyclic sesquiterpenoids as FXR agonists	50
Hepatic TM6SF2 activates antitumour immunity to suppress metabolic dysfunction-associated steatotic liver disease-related hepatocellular carcinoma and boosts immunotherapy	50
Diagnostic dilemma: a patient with diarrhoea	49
Risk of metachronous advanced neoplasia in patients with serrated lesions depending on follow-up schedule	49
Gut microbiota as non-invasive diagnostic and prognostic biomarkers for natural killer/T-cell lymphoma	49
Correction: PMO-29 Switching between infliximab biosimilars: experience from two inflammatory bowel disease centres	49
GI highlights from the literature	49
Correction: Fatty acids promote fatty liver disease via the dysregulation of 3-mercaptopyruvate sulfurtransferase/hydrogen sulfide pathway	49
Prevalence of irritable bowel syndrome and functional dyspepsia after acute gastroenteritis: systematic review and meta-analysis	48
Interplay between diet, circulating indolepropionate concentrations and cardiometabolic health in US populations	48
APC and P53 mutations synergise to create a therapeutic vulnerability to NOTUM inhibition in advanced colorectal cancer	47
Landscape of the gut mycobiome dynamics during pregnancy and its relationship with host metabolism and pregnancy health	47
Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis	47
The Peptidoglycan Recognition Protein 1 confers immune evasive properties on pancreatic cancer stem cells	47
NNMT enriches for AQP5 + cancer stem cells to drive malignant progression in early gastric cardia adenocarcinoma	46
Fungi and cancer	46
Assessment of the yearly carbon emission of a gastrointestinal endoscopy unit	46
IL-20 subfamily cytokines impair the oesophageal epithelial barrier by diminishing filaggrin in eosinophilic oesophagitis	46
Synergistic association of sodium-glucose cotransporter-2 inhibitor and metformin on liver and non-liver complications in patients with type 2 diabetes mellitus and metabolic dysfunction-associated st	45
Human enteric nervous system progenitor transplantation improves functional responses in Hirschsprung disease patient-derived tissue	45
Targeting MYC effector functions in pancreatic cancer by inhibiting the ATPase RUVBL1/2	45
Human milk oligosaccharide 2’-fucosyllactose protects against high-fat diet-induced obesity by changing intestinal mucus production, composition and degradation linked to changes in gut microbiota and	45
Pericyte drives the formation of circulating tumour cell-neutrophil clusters to promote colorectal cancer metastasis	43
Long-term hepatitis B surface antigen response after finite treatment of ARC-520 or JNJ-3989	42
The road to a world-unified approach to the management of patients with gastric intestinal metaplasia: a review of current guidelines	42

Targeting TL1A and DR3: the new frontier of anti-cytokine therapy in IBD	42
GI highlights from the literature	41
Tailoring treatment to the circumstance: reasoning behind metal versus plastic drainage of pancreatic collections	41
Is HBx protein the X factor in the pathogenesis of IBD?	41
Correction: O4 Acceptability and feasibility of a multimodal early detection pilot study for liver disease in high risk groups: “Alright My Liver?”	40
GI snapshot: arrhythmia, dysphagia and weight loss in a 71-year-old man	40
Correction: Sympathetic nervous activation, mitochondrial dysfunction and outcome in acutely decompensated cirrhosis: the metabolomic prognostic models (CLIF-C MET)	40
Immune-related adverse events are a potent predictor of post-transplant rejection in HCC: a multicentre retrospective cohort study	39
Variceal band ligation and carvedilol: together forever, or not?	39
PDE5A+ cancer-associated fibroblasts enhance immune suppression in gastric cancer	39
Alcohol exhibits contrasting effects on CD8 + T cells in the gut and liver in alcohol-associated liver disease	39
Specific gut pathobionts escape antibody coating and are enriched during flares in patients with severe Crohn’s disease	39
Recent advances in incretin-based therapy for MASLD: from single to dual or triple incretin receptor agonists	39
SARS-CoV-2 Omicron variant infection was associated with higher morbidity in patients with cirrhosis	38
Correction: Macrophages direct cancer cells through a LOXL2-mediated metastatic cascade in pancreatic ductal adenocarcinoma	38
Sex-based differences in prescribed medications, surgical procedures and disease-related complications in IBD	38
Trends and cross-country inequality in the incidence of GI cancers among the working-age population from 1990 to 2021: a Global Burden of Disease 2021 analysis	37
Basal levels of microbiota-driven subclinical inflammation are associated with anastomotic leak in patients with colorectal cancer	37
Simplified Helicobacter pylori therapy for patients with penicillin allergy: a randomised controlled trial of vonoprazan-tetracycline dual therapy	37
Maternal antibiotic exposure during pregnancy and risk of IBD in offspring: a population-based cohort study	37
Gut microbiome and dietary fibre intake strongly associate with IgG function and maturation following SARS-CoV-2 mRNA vaccination	37
Is the significant risk of perioperative complications associated with radical surgery following non-curative endoscopic submucosal dissection for early colorectal cancer still acceptable?	37
Cold versus hot snare endoscopic mucosal resection for large (≥15 mm) flat non-pedunculated colorectal polyps: a randomised controlled trial	36
Establishment of a validated central reading system for ileocolonoscopy in an academic setting	36
Endocytoscopy with automated multispectral intestinal barrier pathology imaging for assessment of deep healing to predict outcomes in ulcerative colitis	36
Effectiveness of mailed outreach and patient navigation to promote HCC screening process completion: a multicentre pragmatic randomised clinical trial	35
Vessel and tissue recognition during third-space endoscopy using a deep learning algorithm	35
HBV integrations reshaping genomic structures promote hepatocellular carcinoma	35
Cellular immunotherapies and immune cell depleting therapies in inflammatory bowel diseases: the next magic bullet?	35
DYRK1B blockade promotes tumoricidal macrophage activity in pancreatic cancer	35
Eosinophils: a novel therapeutic target to promote liver regeneration in acute liver injury?	34
Alterations to the duodenal microbiota are linked to gastric emptying and symptoms in functional dyspepsia	34
CAF-macrophage crosstalk in tumour microenvironments governs the response to immune checkpoint blockade in gastric cancer peritoneal metastases	34
Organoids in gastrointestinal diseases: from experimental models to clinical translation	34
Single-cell omics in inflammatory bowel disease: recent insights and future clinical applications	34
Nuclear translocation of plasma membrane protein ADCY7 potentiates T cell-mediated antitumour immunity in HCC	33
Artificial intelligence applied to ‘omics data in liver disease: towards a personalised approach for diagnosis, prognosis and treatment	33
Hereditary diffuse gastric cancer spectrum associated with germline CTNNA1 loss of function revealed by clinical and molecular data from 351 carrier fami	33
Liver stiffness thresholds to predict disease progression and clinical outcomes in bridging fibrosis and cirrhosis	33
Combining ferroptosis induction with MDSC blockade renders primary tumours and metastases in liver sensitive to immune checkpoint blockade	33
British Society of Gastroenterology guidelines for the diagnosis and management of cholangiocarcinoma	33
Phenotypic CD8 T cell profiling in chronic hepatitis B to predict HBV-specific CD8 T cell susceptibility to functional restoration in vitro	33
Response to: ‘Differentiating gastroparesis from functional dyspepsia is no longer sufficient’ by O’Grady et al	32
Rise of precision medicine: can it deliver on its promise in IBD?	32
Accuracy of measuring colorectal polyp size in pathology: a prospective study	32
Precancerous nature of intestinal metaplasia with increased chance of conversion and accelerated DNA methylation	32
Correction: British Society of Gastroenterology guidelines on inflammatory bowel disease in adults: 2025	31
More than meets the eye: a strange cause of bowel obstruction and perforation	31
Genetic and transcriptomic landscape of colonic diverticulosis	31
Post-acute COVID-19 syndrome and gut dysbiosis linger beyond 1 year after SARS-CoV-2 clearance	31
Adherent-invasive Escherichia coli in Crohn’s disease: the 25th anniversary	31
Over-the-scope-clips versus standard treatment in high-risk patients with acute non-variceal upper gastrointestinal bleeding: a randomised controlled trial (STING-2)	31
Stressed hepatocyte sustains alcohol-associated hepatitis progression by producing leukocyte cell-derived chemotaxin 2	31
Intravital imaging: dynamic insights into liver immunity in health and disease	30
Ferritin—a promising biomarker in MASLD	30
Response to ‘Biliary sludge and microlithiasis: are we covering the full spectrum of lithogenic biliary disorders?’	30
Global prevalence of self-reported non-coeliac gluten and wheat sensitivity: a systematic review and meta-analysis	30
Key metabolomic alterations are associated with ulcerative colitis disease state and activity: a validation analysis	30
Congenital sucrase-isomaltase mutations worsen IBS-linked V15F dysfunction and trafficking	30
Presenilins: the hidden guardians of gut health in Alzheimer’s disease	29
An unusual cause of oesophageal stricture	29
Patient-reported experience of colonoscopy in Italy: a multicentre prospective observational study	29
Germline mutations and pancreatic cancer risk in chronic pancreatitis	29
DNA-methylation signature accurately differentiates pancreatic cancer from chronic pancreatitis in tissue and plasma	29
Cutting waste in endoscopy: the roles of professional practice and staffing levels	29
Gnotobiotic mice housing conditions critically influence the phenotype associated with transfer of faecal microbiota in a context of obesity	29
MAFLD, HCC and the dilemma of (changing) terminology in liver diseases	29
Is the biogeography of the mucosa-associated microbiota a key factor affecting primary sclerosing cholangitis disease course and treatment?	28
Correction: Residual SARS-CoV-2 viral antigens detected in GI and hepatic tissues from five recovered patients with COVID-19	28
Response to the letter to the editor ‘revisiting lipid dysregulation in colorectal cancer: critical appraisal of pro-inflammatory bias and therapeutic implications’	28
Clinical outcome of non-curative endoscopic submucosal dissection for early colorectal cancer	28
Cold versus hot EMR for large duodenal adenomas	28
Purastat post-EMR: unresolved questions from the PURPLE trial	28
Omega-3 polyunsaturated fatty acids: moving towards precision use for prevention and treatment of colorectal cancer	28
Reply to Newmanet al‘Response to epidemiology of inflammatory bowel disease in men with high-risk homosexual activity’	28
eCura and W-eCura: different scores, different populations, same goal	28
Purified oat protein can trigger acute symptoms linked to immune activation in coeliac disease patients but not histological deterioration	27
Correction: O11 Utilising peer support workers in hepatitis C screening in emergency departments: a pilot study	27
Patient selection for urgent endoscopic retrograde cholangio-pancreatography by endoscopic ultrasound in predicted severe acute biliary pancreatitis (APEC-2): a multicentre prospective study	27
Unusual cause of abdominal pain	27
Toxic microbiome and progression of chronic kidney disease: insights from a longitudinal CKD-microbiome study	27
Fibroblast pentose phosphate pathway activation upon decreased circPLCE1 exacerbates intestinal fibrosis in Crohn’s disease	27
Inhibition of YTHDF1 by salvianolic acid overcomes gluten-induced intestinal inflammation	27
CD177+ neutrophils: new drivers of liver regeneration	26
CRIP1 fosters MDSC trafficking and resets tumour microenvironment via facilitating NF-κB/p65 nuclear translocation in pancreatic ductal adenocarcinoma	26
Hepatocyte guardian: A20 restrains ferroptosis in autoimmune hepatitis	26
Reconsidering statins in MASLD: beyond cardiovascular protection to multisystem benefit	26
Mapping the human gut mycobiome in middle-aged and elderly adults: multiomics insights and implications for host metabolic health	26
Porcine-derived pancreatic enzyme replacement therapy: a cause of hepatitis E virus transmission?	26
Performance of the China-CLIF framework in acute-on-chronic liver failure: a multicohort study across all aetiologies	26
Smoking affects gut immune system of patients with inflammatory bowel diseases by modulating metabolomic profiles and mucosal microbiota	25
Lack of inflammatory bowel disease flare-up following two-dose BNT162b2 vaccine: a population-based cohort study	25
World Gastroenterology Organisation - Gut commentary series on digestive health and climate change	25
Undiagnosed inflammatory bowel disease among individuals undergoing colorectal cancer screening: a nationwide Danish cohort study 2014–2018	25
GI highlights from the literature	25